2001
DOI: 10.1038/sj.onc.1204952
|View full text |Cite
|
Sign up to set email alerts
|

Conservation of mononucleotide repeats within 3′ and 5′ untranslated regions and their instability in MSI-H colorectal cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
22
0

Year Published

2005
2005
2023
2023

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 27 publications
(25 citation statements)
references
References 28 publications
3
22
0
Order By: Relevance
“…Figure 3, A-C shows the numbers of deletion mutations in their UTRs. MSs with longer repeat lengths exhibited a higher instability rate, which led to multiple nucleotide deletions (Suraweera et al 2001). Taken together, these results demonstrate that the number of candidate genes with MS mutations is markedly greater than had been previously known (Suraweera et al 2001;Kim et al 2002;Woerner et al 2003;Royrvik et al 2007;Shin et al 2011).…”
Section: Characterization Of Repeat Sequence Tract Instabilities In Gsupporting
confidence: 56%
“…Figure 3, A-C shows the numbers of deletion mutations in their UTRs. MSs with longer repeat lengths exhibited a higher instability rate, which led to multiple nucleotide deletions (Suraweera et al 2001). Taken together, these results demonstrate that the number of candidate genes with MS mutations is markedly greater than had been previously known (Suraweera et al 2001;Kim et al 2002;Woerner et al 2003;Royrvik et al 2007;Shin et al 2011).…”
Section: Characterization Of Repeat Sequence Tract Instabilities In Gsupporting
confidence: 56%
“…MNRs in UTRs are evolutionary conserved, indicating a functional role (20). Repeat sequences are prone to alteration in cancers with defect mismatch repair (MSI), and some of the alterations are involved in the regulation of gene and protein expression.…”
Section: Discussionmentioning
confidence: 99%
“…In all cases the repeat was conserved, ie monomorphic. 10 Subsequently, 70 MSI-H colon tumour specimens were tested from patients complying with the clinical Bethesda criteria, 1 38 of whom a germ line mutation was identified in one of the MMR genes. MSI in the repeat was found in tumours from 12 of 20 (60%) hMLH1 patients, 6 of 12 (50%) hMSH2 patients, 2 of 6 (33%) hMSH6 patients, in 21 of 32 (66%) of the residual MSI-H tumours and in 4 of 4 (100%) MSI-H colon cancer cell lines.…”
Section: Resultsmentioning
confidence: 99%